A carregar...
INT-003 The use of proton pump inhibitors in hospitalised patients
BACKGROUND: The use of proton pump inhibitors (PPIs) to treat acid-related disorders is increasing worldwide and this raise concerns. Accumulating evidence supports the increased risk of long-term adverse events such as: fractures, C. difficile-associated diarrhoea and pneumonia all associated with...
Na minha lista:
| Publicado no: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535727/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.528 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|